Wilbanks Smith & Thomas Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$1.22M Buy
2,930
+4
+0.1% +$1.67K 0.03% 206
2023
Q4
$1.19M Hold
2,926
0.04% 204
2023
Q3
$1.02M Buy
2,926
+22
+0.8% +$7.65K 0.04% 224
2023
Q2
$1.02M Sell
2,904
-50
-2% -$17.6K 0.03% 220
2023
Q1
$931K Sell
2,954
-6
-0.2% -$1.89K 0.03% 225
2022
Q4
$855K Sell
2,960
-3
-0.1% -$866 0.03% 237
2022
Q3
$858K Sell
2,963
-13
-0.4% -$3.76K 0.04% 231
2022
Q2
$839K Buy
2,976
+23
+0.8% +$6.48K 0.04% 235
2022
Q1
$795K Buy
2,953
+60
+2% +$16.2K 0.03% 244
2021
Q4
$635K Sell
2,893
-19
-0.7% -$4.17K 0.02% 298
2021
Q3
$528K Sell
2,912
-18
-0.6% -$3.26K 0.02% 296
2021
Q2
$591K Sell
2,930
-134
-4% -$27K 0.02% 286
2021
Q1
$658K Sell
3,064
-121
-4% -$26K 0.03% 254
2020
Q4
$753K Buy
3,185
+17
+0.5% +$4.02K 0.04% 221
2020
Q3
$862K Hold
3,168
0.05% 186
2020
Q2
$920K Buy
3,168
+110
+4% +$31.9K 0.06% 171
2020
Q1
$728K Buy
3,058
+197
+7% +$46.9K 0.05% 185
2019
Q4
$626K Hold
2,861
0.04% 219
2019
Q3
$485K Hold
2,861
0.03% 235
2019
Q2
$525K Hold
2,861
0.03% 225
2019
Q1
$526K Hold
2,861
0.03% 226
2018
Q4
$474K Hold
2,861
0.03% 210
2018
Q3
$551K Hold
2,861
0.03% 227
2018
Q2
$486K Buy
2,861
+46
+2% +$7.81K 0.04% 198
2018
Q1
$459K Hold
2,815
0.04% 203
2017
Q4
$422K Sell
2,815
-618
-18% -$92.6K 0.03% 216
2017
Q3
$522K Buy
3,433
+618
+22% +$94K 0.04% 190
2017
Q2
$363K Hold
2,815
0.03% 213
2017
Q1
$308K Hold
2,815
0.03% 225
2016
Q4
$207K Hold
2,815
0.02% 284
2016
Q3
$245K Sell
2,815
-40
-1% -$3.48K 0.02% 244
2016
Q2
$246K Hold
2,855
0.03% 249
2016
Q1
$227K Hold
2,855
0.03% 253
2015
Q4
$359K Hold
2,855
0.04% 186
2015
Q3
$297K Hold
2,855
0.04% 198
2015
Q2
$353K Sell
2,855
-24
-0.8% -$2.97K 0.03% 218
2015
Q1
$340K Buy
2,879
+43
+2% +$5.08K 0.03% 211
2014
Q4
$337K Buy
2,836
+21
+0.7% +$2.5K 0.03% 220
2014
Q3
$316K Hold
2,815
0.03% 206
2014
Q2
$267K Buy
+2,815
New +$267K 0.03% 241
2014
Q1
Sell
-2,815
Closed -$209K 303
2013
Q4
$209K Sell
2,815
-28
-1% -$2.08K 0.02% 267
2013
Q3
$216K Sell
2,843
-19
-0.7% -$1.44K 0.03% 250
2013
Q2
$229K Buy
+2,862
New +$229K 0.04% 227